FARALLON CAPITAL MANAGEMENT LLC
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 909661
SAN FRANCISCO, CA
Position in AGIO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$219,594,714
+$27,304,994 QoQ
Shares Held
5,917,400
+4.1% QoQ
Ownership
9.91%
of shares outstanding
% of Portfolio
1.30%
of 13F equity value
Holder Rank
#2
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $7,398,148,665 across 26 Biotechnology names. AGIO ranks #11 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,670,881 | $2,537,793,074 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
10,743,063 | $800,143,332 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $778,248,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,468,010 | $732,794,424 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
14,309,000 | $506,395,510 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
12,277,000 | $383,779,020 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,236,396 | $351,313,110 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,989,098 | $336,372,047 |
All Filings in AGIO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,594,714 | 5,917,400 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $192,289,720 | 5,684,000 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $140,441,726 | 5,159,505 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $232,051,989 | 5,781,066 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $191,825,919 | 5,767,466 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $167,023,653 | 5,700,466 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $186,462,952 | 5,674,466 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $251,512,276 | 5,660,866 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $243,822,126 | 5,654,502 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $163,469,202 | 5,590,602 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $92,812,496 | 4,167,602 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $68,083,017 | 2,750,829 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $76,147,637 | 2,688,829 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $48,072,282 | 2,092,829 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $56,885,278 | 2,025,829 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $42,330,324 | 1,496,829 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $29,552,876 | 1,333,012 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $38,803,979 | 1,333,012 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $41,303,718 | 1,256,578 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $37,786,097 | 818,767 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $63,927,600 | 1,160,000 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $64,550,000 | 1,250,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $43,330,000 | 1,000,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $37,920,015 | 1,083,429 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $66,850,000 | 1,250,000 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $44,350,000 | 1,250,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||